Arkolith/Insider Trading/SBTX/Form 4

Shawver Laura

Chief Executive Officer, DirectorSilverback Therapeutics, Inc. (SBTX) · full profile →Form 4 · filed Aug 9, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 5, 2022Option exercise(M)79K$1.27$100K254K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 5, 2022Option exercise(M)79K—$0403K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-045023) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML